Christina J Bathgate1, Julio Fernandez-Mendoza2. 1. Department of Medicine, National Jewish Health, Denver, CO, USA. 2. Sleep Research & Treatment Center, Penn State Health Milton S. Hershey Medical Center, Pennsylvania State University College of Medicine, 500 University Dr. H073, Hershey, PA, USA. jfmendoza@psu.edu.
Abstract
PURPOSE OF REVIEW: To summarize research from the past 2 years on the association between insomnia, short sleep duration, and hypertension and provide a critical analysis of the evidence and suggestions for future directions in this field. RECENT FINDINGS: Evidence indicates that the association between insomnia and elevated blood pressure (BP) or stage 1 and 2 hypertension is stronger in those with chronic insomnia, as compared to those with isolated insomnia symptoms, and primarily found in those with the insomnia with objective short sleep duration phenotype. There is a key gap in ambulatory BP monitoring across the sleep-wake cycle as well as in randomized clinical trials testing the effectiveness of pharmacological or cognitive-behavioral insomnia therapies in lowering BP. Insomnia is a strong candidate to join the list of risk factors for hypertension along with obstructive sleep apnea. In the meantime, chronic insomnia should become part of the routine assessment of patients with elevated BP and should be a source for referral, diagnostic evaluation, and treatment, rather than regarded as a symptom of the underlying medical disorder.
PURPOSE OF REVIEW: To summarize research from the past 2 years on the association between insomnia, short sleep duration, and hypertension and provide a critical analysis of the evidence and suggestions for future directions in this field. RECENT FINDINGS: Evidence indicates that the association between insomnia and elevated blood pressure (BP) or stage 1 and 2 hypertension is stronger in those with chronic insomnia, as compared to those with isolated insomnia symptoms, and primarily found in those with the insomnia with objective short sleep duration phenotype. There is a key gap in ambulatory BP monitoring across the sleep-wake cycle as well as in randomized clinical trials testing the effectiveness of pharmacological or cognitive-behavioral insomnia therapies in lowering BP. Insomnia is a strong candidate to join the list of risk factors for hypertension along with obstructive sleep apnea. In the meantime, chronic insomnia should become part of the routine assessment of patients with elevated BP and should be a source for referral, diagnostic evaluation, and treatment, rather than regarded as a symptom of the underlying medical disorder.
Entities:
Keywords:
Autonomic nervous system; High blood pressure; Hyperarousal; Hypertension; Insomnia; Short sleep duration
Authors: Julio Fernandez-Mendoza; Alexandros N Vgontzas; Duanping Liao; Michele L Shaffer; Antonio Vela-Bueno; Maria Basta; Edward O Bixler Journal: Hypertension Date: 2012-08-14 Impact factor: 10.190
Authors: Alexandros N Vgontzas; Duanping Liao; Edward O Bixler; George P Chrousos; Antonio Vela-Bueno Journal: Sleep Date: 2009-04 Impact factor: 5.849
Authors: Anna F Johann; Elisabeth Hertenstein; Simon D Kyle; Chiara Baglioni; Bernd Feige; Christoph Nissen; Alastair J McGinness; Dieter Riemann; Kai Spiegelhalder Journal: PLoS One Date: 2017-07-26 Impact factor: 3.240
Authors: Caroline Y Doyle; John M Ruiz; Daniel J Taylor; Joshua W Smyth; Melissa Flores; Jessica R Dietch; Chul Ahn; Matthew Allison; Timothy W Smith; Bert N Uchino Journal: Psychosom Med Date: 2019 Jul/Aug Impact factor: 4.312
Authors: Mohammed Siddiqui; T J Moore; Dustin M Long; Greer A Burkholder; Amanda Willig; Christina Wyatt; Sonya Heath; Paul Muntner; Edgar Turner Overton Journal: AIDS Res Hum Retroviruses Date: 2022-08-23 Impact factor: 1.723
Authors: Xiaoyu Li; Daniela Sotres-Alvarez; Linda C Gallo; Alberto R Ramos; Larissa Aviles-Santa; Krista M Perreira; Carmen R Isasi; Phyllis C Zee; Kimberly L Savin; Neil Schneiderman; Sylvia Wassertheil-Smoller; Tamar Sofer; Martha Daviglus; Susan Redline Journal: Am J Respir Crit Care Med Date: 2021-02-01 Impact factor: 21.405